scholarly journals Blood Pressure Differences Associated With Optimal Macronutrient Intake Trial for Heart Health (OMNIHEART)–Like Diet Compared With a Typical American Diet

Hypertension ◽  
2014 ◽  
Vol 64 (6) ◽  
pp. 1198-1204 ◽  
Author(s):  
John Molitor ◽  
Ian J. Brown ◽  
Queenie Chan ◽  
Michail Papathomas ◽  
Silvia Liverani ◽  
...  
1988 ◽  
Vol 6 (11) ◽  
pp. 944
Author(s):  
W C S Smith ◽  
I K Crombie ◽  
R Tavendale ◽  
H D Tunstall-Pedoc

2018 ◽  
Vol 16 (Suppl 1) ◽  
pp. S29-S34 ◽  
Author(s):  
Kamal H. Henderson ◽  
Darren A. DeWalt ◽  
Jacquie Halladay ◽  
Bryan J. Weiner ◽  
Jung I. Kim ◽  
...  

2017 ◽  
Vol 117 (3) ◽  
pp. 450-456 ◽  
Author(s):  
Aila J. Ahola ◽  
Valma Harjutsalo ◽  
Lena M. Thorn ◽  
Riitta Freese ◽  
Carol Forsblom ◽  
...  

AbstractDiet is a major modifiable lifestyle factor that may affect the components of the metabolic syndrome. We aimed to investigate the association between relative proportions of macronutrients and the components of the metabolic syndrome in a population of individuals with type 1 diabetes. In all, 791 individuals without nephropathy, with plausible energy intake and known metabolic syndrome status, taking part in the Finnish Diabetic Nephropathy Study were included in the analyses. Dietary data were collected with a diet record. The association between the relative macronutrient intake and the outcome variables were analysed using multivariable nutrient density substitution models. The relative proportions of dietary macronutrients or fatty acids were not associated with the presence of the metabolic syndrome. In men, however, favouring carbohydrates over fats was associated with lower odds of the waist component, whereas favouring either carbohydrates or fats over proteins was associated with lower odds of the blood pressure component of the metabolic syndrome. In women, substituting carbohydrates for fats was associated with lower HDL-cholesterol concentration. Substituting carbohydrates or fats for alcohol or protein was, in men, associated with lower systolic blood pressure. To conclude, the relative distribution of macronutrients may have some relevance for the metabolic syndrome.


2021 ◽  
Vol 5 (Supplement_2) ◽  
pp. 377-377
Author(s):  
Alexandra Uhren ◽  
Maria Morgan-Bathke ◽  
Kelsey McLimans

Abstract Objectives Determine if a four-week kombucha intervention improves cardiometabolic parameters in human participants. Methods 25 participants, aged 18–53 with BMIs from 18.6–35.4, consumed four ounces of kombucha daily for four weeks. Blood pressure, body composition, blood glucose, lipid panel, and maximal oxygen uptake were assessed pre- and post-kombucha intervention. Linear Regressions and Paired T-tests were run through Jamovi to determine significance. Results The association between kombucha consumption and lipid panel (Triglycerides P = 0.958)(HDL P = 0.894)(LDL P = 0.424)(Total Cholesterol P = 0.373)(Blood Glucose P = 0.583), blood pressure (Systolic P = 0.526)(Diastolic P = 0.707), maximal oxygen uptake (P = 0.881), BMI (P = 0.889), and body fat composition (P = 0.791) were not significant. Food Frequency Questionnaires (FFQ) provided additional data on participants' dietary intake including added sugar, carbohydrate, protein, fat, dairy, fiber and total calories. FFQ were used to determine if kombucha supplementation would be beneficial even in a diet with excessive or insufficient macronutrient intake. There was a significant decrease in added sugar (P = 0.008), carbohydrate (P = 0.002), protein (P = 0.002), fat (P = 0.003), dairy (P = 0.015), fiber (P = 0.014), and caloric intake (P = 0.002) consumption during the intervention. Conclusions Despite various health claims made about kombucha, the kombucha intervention used did not have a significant impact on the cardiometabolic measurements evaluated. Most participants were primarily lean which may explain why no significance was found in these parameters. It appeared that kombucha consumption had a significant effect on reported dietary intake with overall caloric intake (kcal) and macronutrient intake decreasing during the intervention. This may be due to kombucha suppressing appetite or making participants feel fuller due to the fluid volume. This may lead to weight loss over time which in turn would improve cardiometabolic parameters. These findings are valuable to researchers when determining future clinical recommendations for kombucha consumption and exploration of dose-response to kombucha. Further research should have longer interventions and broader ranges of BMI to better determine effects. Funding Sources The research was funded by Viterbo University.


Author(s):  
Laufey Hrolfsdottir ◽  
Thorhallur I. Halldorsson ◽  
Dorte Rytter ◽  
Bodil Hammer Bech ◽  
Bryndis E. Birgisdottir ◽  
...  

2021 ◽  
Vol 20 (10) ◽  
pp. 854-867
Author(s):  
Priya Palta ◽  
Marilyn S Albert ◽  
Rebecca F Gottesman

Circulation ◽  
2020 ◽  
Vol 141 (Suppl_1) ◽  
Author(s):  
Stephen P Juraschek ◽  
Lara C Kovell ◽  
Lawrence J Appel ◽  
Edgar R Miller ◽  
Frank M Sacks ◽  
...  

Background: The Dietary Approaches to Stop Hypertension (DASH) diet (rich in fruit (F), vegetables (V), low-fat dairy, and fiber, and reduced in saturated fat and cholesterol) lowered blood pressure (BP) and low-density lipoprotein cholesterol after 8 weeks compared with a typical American diet. However, direct effects on cardiovascular damage are unknown. Hypothesis: The DASH diet reduces cardiac injury, strain, and inflammation compared to a typical American diet. Methods: The DASH feeding study was a 3-arm, parallel-design, randomized controlled trial of adults with systolic BP (SBP) <160 mm Hg and diastolic BP (DBP) of 80-95 mm Hg, without cardiovascular disease (CVD) and not taking BP medications. Participants were randomized to 8 weeks of monitored feeding with: a typical American diet with 3.6 servings of F/V per day (ref), a F/V-enriched diet (8.5 servings of F/V per day), or the DASH diet (9.6 servings of F/V per day). Calories were adjusted to keep weight constant throughout feeding. We compared the effects of these diets on 3 cardiac biomarkers: high-sensitivity cardiac troponin I (hs-cTnI), N-terminal b-type pro natriuretic peptide (NT-proBNP), and high-sensitivity C-reactive protein (hs-CRP), measured in stored serum collected at baseline and after feeding. Results: Of the 257 participants with available specimens, 33% were aged >50 yrs, 48% were women, and 56% were non-white. Mean baseline SBP/DBP was 131/85 mmHg. Compared to control, the F/V-enriched diet reduced hs-cTnI by 53% (95% CI: 18, 73; P = 0.008) and NT-proBNP by 24% (95% CI: 7, 38; P = 0.01) ( Figure ). Similarly, compared to control, DASH reduced hs-cTnI by 49% (95% CI: 11, 71; P = 0.02) and NT-proBNP by 20% (95% CI: 2, 35; P = 0.04). Hs-CRP did not differ between diets, and none of the markers differed between DASH and F/V-enriched diets. Conclusions: In adults with high BP but not CVD, both F/V-enriched and DASH diets lowered sensitive markers of cardiac injury and strain over 8 weeks. Our study demonstrates early, direct cardiovascular benefits from diets rich in F/V.


2009 ◽  
Vol 157 (2) ◽  
pp. 278-284 ◽  
Author(s):  
Denise E. Bonds ◽  
Patricia E. Hogan ◽  
Alain G. Bertoni ◽  
Haiying Chen ◽  
C. Randall Clinch ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document